Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 1 Biospecimen handling pipeline

Published byAubrie Clarke Modified over 5 years ago

Similar presentations

Presentation on theme: "Figure 1 Biospecimen handling pipeline"— Presentation transcript:

1 Figure 1 Biospecimen handling pipeline
Figure 1 | Biospecimen handling pipeline. Establishing standard operating procedures for collection and handling of samples and data is a critical first step in ensuring high-quality translational research. Preanalytical variables can affect various steps of the pipeline, from specimen collection to downstream analysis. Key preanalytical variables include those relating to the patient's individual physiology (green), the uniformity of biospecimen collection (blue) and biospecimen handling procedures (pink). Quality control assays can highlight sample adequacy, confirm optimal sample processing and/or storage and predict the validity of downstream analysis. Yeung, R. S. M. et al. (2016) Enhancing translational research in paediatric rheumatology through standardization Nat. Rev. Rheumatol. doi: /nrrheum

Download ppt "Figure 1 Biospecimen handling pipeline"

Similar presentations

Table 3 Limb-girdle muscular dystrophy standardized data collection form and HPO mapping Thompson, R. & Straub, V. et al. (2016) Limb-girdle muscular dystrophies.

Table 3 Limb-girdle muscular dystrophy standardized data collection form and HPO mapping Thompson, R. & Straub, V. et al. (2016) Limb-girdle muscular dystrophies.
Patient Biospecimen Preanalytics:

Patient Biospecimen Preanalytics:
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 4 Tissue infiltration and lymphadenopathy in patients with CTLA4 mutations Figure 4 | Tissue infiltration and lymphadenopathy in patients with CTLA4.

Figure 4 Tissue infiltration and lymphadenopathy in patients with CTLA4 mutations Figure 4 | Tissue infiltration and lymphadenopathy in patients with CTLA4.
Figure 3 Connexins in cartilage

Figure 3 Connexins in cartilage
Figure 2 Representative MSI data obtained from human joints

Figure 2 Representative MSI data obtained from human joints
Figure 1 Rheumatoid arthritis development over time in relation to the level of inflammation Figure 1 | Rheumatoid arthritis development over time in relation.

Figure 1 Rheumatoid arthritis development over time in relation to the level of inflammation Figure 1 | Rheumatoid arthritis development over time in relation.
Figure 1 Grip strength across the lifecourse

Figure 1 Grip strength across the lifecourse
Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum
Figure 1 Factors underlying metabolic alterations in osteoarthritis

Figure 1 Factors underlying metabolic alterations in osteoarthritis
Figure 1 Induction of immune tolerance

Figure 1 Induction of immune tolerance
Figure 2 Risk factors for sarcopenia

Figure 2 Risk factors for sarcopenia
Figure 4 Ex vivo synovial tissue culture viability

Figure 4 Ex vivo synovial tissue culture viability
Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum
Figure 5 Defects in the JAK–STAT signalling pathway

Figure 5 Defects in the JAK–STAT signalling pathway
Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum
Figure 2 Targeted versus untargeted metabolomics approaches

Figure 2 Targeted versus untargeted metabolomics approaches
Figure 1 Metabolic profiling as a tool for studying rheumatic diseases

Figure 1 Metabolic profiling as a tool for studying rheumatic diseases

Similar presentations

Ads by Google